Mobile

A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis

Update Il y a 5 ans
Reference: EUCTR2004-004558-18

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the efficacy of cinacalcet compared with placebo by determining the proportion of subjects achieving a mean reduction of ≥ 30% in intact parathyroid hormone (iPTH) during the efficacy assessment phase.

Inclusion criteria

  • Secondary Hyperparathyroidism in Chronic Kidney Disease subjects not receiving dialysis

Links